MDI-403
MDI-403 is a retinoic acid receptor (RAR) agonist with an EC50 value of less than 1 μM. MDI-403 exhibits significant antiviral activity against SARS-CoV-2, and can dose-dependently inhibit the expression of viral nucleoprotein (NP) and reduce the proportion of infected cells. MDI-403 mainly acts during the virus invasion stage. MDI-403 can be used in research on anti-SARS-CoV-2.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 127471-94-7
- 分子式: C29H36O4
- 分子量:448.59
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
化学情報
-
CAS 番号 127471-94-7
-
分子量 448.59
-
分子式 C29H36O4
-
SMILES
C(=C/C(=C/C=C/C(=C\C(OCC(=O)C1=CC=C(OC)C=C1)=O)/C)/C)\C=2C(C)(C)CCCC2C
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- MDI-403
- 127471-94-7
- MDI403
- MDI 403
- RAR/RXR
- SARS-CoV
- Retinoic acid receptors
- Retinoid X receptors
- SARS coronavirus
- SARS-CoV-2
- drug repurposing
- ReFRAME library
- antiviral compounds
- RAR agonist
- high-throughput screening
- viral replication inhibition
- Vero E6 cells
- dose-response
- synergy with remdesivir
- Inhibitor
- inhibitor
- inhibit